# Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Source: https://onco.cc/key-papers/paper-andrew-lassman-neuro-oncol-2020/  
OnCo record `paper-andrew-lassman-neuro-oncol-2020` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Paper by Andrew B. Lassman indexed on Europe PMC as PubMed record 32328653, in Neuro-Oncology (2020), one of the most cited records naming an author with this name at Herbert Irving Comprehensive Cancer Center, Columbia University.

## Summary

Glioblastomas are the most common form of malignant primary brain tumor and an important cause of morbidity and mortality. In recent years there have been important advances in understanding the molecular pathogenesis and biology of these tumors, but this has not translated into significantly improved outcomes for patients. In this consensus review from the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO), the current management of isocitrate dehydrogenase wildtype (IDHwt) glioblastomas will be discussed. In addition, novel therapies such as targeted molecular therapies, agents targeting DNA damage response and metabolism, immunotherapies, and viral therapies will be reviewed, as well as the current challenges and future directions for research.

Indexed on Europe PMC as PubMed record 32328653 (DOI 10.1093/neuonc/noaa106). Its author list gives "Lassman AB" with the affiliation "Department of Neurology and Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA", which names Herbert Irving Comprehensive Cancer Center, Columbia University; that is how the record was matched to Andrew B. Lassman, and no figure has been checked by an editor.

## Fields

- Kind: Key paper
- Last checked: 2026-09-22
- Tags: europepmc-ingest
- Journal: Neuro-Oncology
- Year: 2020
- DOI: 10.1093/neuonc/noaa106
- Authors: Wen PY, Weller M, Lee EQ, et al.
- What it means: One of the most cited papers Europe PMC returns for Andrew B. Lassman at Herbert Irving Comprehensive Cancer Center, Columbia University, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
- Caveats: Matched to the person by surname, initials and an affiliation string naming the institution on the Europe PMC record; the summary reproduces the record's abstract and no figure has been verified against the full paper.; Two authors sharing a surname, initials and institution cannot be told apart by this method; the person's profile links are the place to confirm authorship.

## Sources

- Neuro Oncol 2020: https://doi.org/10.1093/neuonc/noaa106
- PubMed: https://pubmed.ncbi.nlm.nih.gov/32328653/
- Europe PMC: https://europepmc.org/article/MED/32328653

## Connected records

- people: [Andrew B. Lassman](https://onco.cc/people/andrew-lassman/)
- journals: [Neuro-Oncology](https://onco.cc/journals/neuro-oncology/)

---
JSON: https://onco.cc/api/v1/entities/paper-andrew-lassman-neuro-oncol-2020.json